ANEMIJA SRPASTIH STANICA
Sprečavanje krize
hrvatski
Sprečavanje krize
/assets/ct/7e6416ec85/images/syn_placeholder_sqr.png

Anemija srpastih stanica

Sprečavanje krize

Farmakološka indukcija fetalnog hemoglobina

Safety of hydroxyurea in pregnancy: a systematic review of the literature. (otvara se novi prozor)

Al Sulaimani R, Zitoun N, Alothman H, Hutson JR, Garcia-Bournissen F

Izvor‎: J Obstet Gynaecol Can. 2025 Jul;47(7):102924.

Indeks‎: PubMed 40381805

DOI‎: 10.1016/j.jogc.2025.102924

https://pubmed.ncbi.nlm.nih.gov/40381805/ (otvara se novi prozor)

Outcomes of pregnancies in sickle cell patients treated with hydroxyurea : findings from the escort-HU cohort studies. (otvara se novi prozor)

Anoosha Habibi, Maryse Etienne-Julan, Maria Dimopoulou, Gylna Loko, Pagona Flevari, Narcisse Elenga, Sylvain LE Jeune, Estelle Jean, Laura Thomas-Bourgneuf, Jean-Benoit Arlet, Stephanie NGO, Emmanuelle Bernit, Corinne Charneau, Justine Dautremer, Laure Joseph, Giovanna Cannas, Pablo Bartolucci

Izvor‎: Blood 2025;146(Suppl 1):2-3.

Indeks‎: DOI

DOI‎: 10.1182/blood-2025-2

https://ashpublications.org/blood/article/146/Supplement%201/2/553643/Outcomes-of-pregnancies-in-sickle-cell-patients (otvara se novi prozor)

Systematic review: hydroxyurea for the treatment of adults with sickle cell disease. (otvara se novi prozor)

Lanzkron S, Strouse JJ, Wilson R, Beach MC, Haywood C, Park H, Witkop C, Bass EB, Segal JB.

Izvor‎: Ann Intern Med 2008;148(12):939-55.

Indeks‎: PubMed 18458272

https://www.ncbi.nlm.nih.gov/pubmed/18458272 (otvara se novi prozor)

Hydroxyurea for the treatment of sickle cell anemia. (otvara se novi prozor)

Platt OS.

Izvor‎: N Engl J Med 2008;358(13):1362-9.

Indeks‎: PubMed 18367739

DOI‎: 10.1056/NEJMct0708272

https://www.ncbi.nlm.nih.gov/pubmed/18367739 (otvara se novi prozor)

Clinical effectiveness of decitabine in severe sickle cell disease. (otvara se novi prozor)

Saunthararajah Y, Molokie R, Saraf S, Sidhwani S, Gowhari M, Vara S, Lavelle D, DeSimone J.

Izvor‎: Br J Haematol 2008;141(1):126-9.

Indeks‎: PubMed 18324975

DOI‎: 10.1111/j.1365-2141.2008.07027.x

https://www.ncbi.nlm.nih.gov/pubmed/18324975 (otvara se novi prozor)

The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). (otvara se novi prozor)

Voskaridou E, Christoulas D, Bilalis A, Plata E, Varvagiannis K, Stamatopoulos G, Sinopoulou K, Balassopoulou A, Loukopoulos D, Terpos E.

Izvor‎: Blood 2010;115(12):2354-63.

Indeks‎: PubMed 19903897

DOI‎: 10.1182/blood-2009-05-221333

https://www.ncbi.nlm.nih.gov/pubmed/19903897 (otvara se novi prozor)

Prevencija infekcija i drugih komplikacija

Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. (otvara se novi prozor)

Hirst C, Owusu-Ofori S.

Izvor‎: Cochrane Database Syst Rev 2012;(9):CD003427.

Indeks‎: PubMed 22972063

DOI‎: 10.1002/14651858.CD003427.pub2

https://www.ncbi.nlm.nih.gov/pubmed/22972063 (otvara se novi prozor)

Sickle cell disease. (otvara se novi prozor)

Meremikwu MM, Okomo U.

Izvor‎: BMJ Clin Evid 2011;02:2402.

Indeks‎: PubMed 21718552

https://www.ncbi.nlm.nih.gov/pubmed/21718552 (otvara se novi prozor)

A phase 3 trial of l-glutamine in sickle cell disease. (otvara se novi prozor)

Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP

Izvor‎: N Engl J Med 2018;379(3):226-35.

Indeks‎: PubMed 30021096

DOI‎: 10.1056/NEJMoa1715971

https://www.ncbi.nlm.nih.gov/pubmed/30021096 (otvara se novi prozor)

Malaria chemoprophylaxis in sickle cell disease. (otvara se novi prozor)

Oniyangi O, Omari AA.

Izvor‎: Cochrane Database Syst Rev 2006;(4):CD003489.

Indeks‎: PubMed 17054173

DOI‎: 10.1002/14651858.CD003489.pub2

https://www.ncbi.nlm.nih.gov/pubmed/17054173 (otvara se novi prozor)